| Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer (NCT00101907) | Amgen | 2004-12-01 |
| Combination Chemotherapy in Treating Patients With Esophageal Cancer (NCT00041262) | Medical Research Council | 2004-11-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery (NCT00448760) | University of Miami | 2004-10-01 |
| Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00217581) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00096031) | SWOG Cancer Research Network | 2004-10-01 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer (NCT00439608) | Brown University | 2004-10-01 |
| NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine (NCT00199849) | Ludwig Institute for Cancer Research | 2004-09-27 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer (NCT00238147) | University of Washington | 2004-09-01 |
| Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer (NCT00629863) | North Wales Organisation for Randomised Trials in Health | 2004-09-01 |
| S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction (NCT00086996) | SWOG Cancer Research Network | 2004-09-01 |
| Avastin and Taxotere for Esophagogastric Cancer (NCT00137813) | Dana-Farber Cancer Institute | 2004-08-01 |
| Trial Comparing Side-to-Side Stapled and Hand-sewn Esophagogastric Anastomosis in Neck (NCT00497549) | All India Institute of Medical Sciences | 2004-07-01 |
| Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer (NCT00063986) | Eastern Cooperative Oncology Group | 2004-06-24 |
| Esophageal Stump Washout (NCT01980394) | Kantonsspital Liestal | 2004-05-01 |
| Doxil Topotecan Doublet Cancer Study (NCT00252889) | Christiana Care Health Services | 2004-05-01 |
| Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer (NCT00477841) | Southeast University, China | 2004-04-01 |
| Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery (NCT00258297) | University of Rochester | 2004-04-01 |
| Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery (NCT00238407) | Swiss Cancer Institute | 2004-03-01 |
| Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer (NCT00281736) | Roswell Park Cancer Institute | 2004-02-01 |
| Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer (NCT00197431) | Hamamatsu University | 2004-01-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. (NCT00209716) | Hokkaido Gastrointestinal Cancer Study Group | 2003-12-01 |
| Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. (NCT00209690) | Hokkaido Gastrointestinal Cancer Study Group | 2003-10-01 |
| A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer (NCT00183807) | University of Southern California | 2003-10-01 |
| Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer (NCT00075738) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2003-10-01 |
| Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia (NCT01894763) | Mayo Clinic | 2003-09-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00281788) | Duke University | 2003-09-01 |
| Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction (NCT00054457) | Alliance for Clinical Trials in Oncology | 2003-09-01 |
| Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00069953) | Radiation Therapy Oncology Group | 2003-09-01 |
| Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00072332) | Memorial Sloan Kettering Cancer Center | 2003-08-01 |
| Quality Of Life Outcomes Following Treatment for Esophageal Cancer (NCT00598117) | Memorial Sloan Kettering Cancer Center | 2003-08-01 |
| Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas (NCT00215995) | H. Lee Moffitt Cancer Center and Research Institute | 2003-07-01 |
| Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus (NCT00066716) | Weill Medical College of Cornell University | 2003-06-01 |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer (NCT00093652) | Roswell Park Cancer Institute | 2003-05-01 |
| Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer (NCT00601692) | Memorial Sloan Kettering Cancer Center | 2003-04-01 |
| Stomach and Esophageal Cancers in Northern Iran (NCT00339742) | National Cancer Institute (NCI) | 2003-03-25 |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer (NCT00072033) | Swiss Cancer Institute | 2003-03-01 |
| Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer (NCT00197444) | Hamamatsu University | 2003-01-01 |
| Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer (NCT00052910) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients (NCT00502502) | M.D. Anderson Cancer Center | 2002-11-01 |
| Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer (NCT00113581) | Merck KGaA, Darmstadt, Germany | 2002-10-01 |
| Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (NCT00040859) | Alliance for Clinical Trials in Oncology | 2002-09-01 |
| Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer (NCT00033657) | Eastern Cooperative Oncology Group | 2002-08-15 |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer (NCT00963092) | Cancer Research UK | 2002-08-01 |
| Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma (NCT01048281) | Stanford University | 2002-08-01 |
| Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer (NCT00759226) | CONKO-Studiengruppe | 2002-07-01 |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract (NCT00012246) | The University of Texas Medical Branch, Galveston | 2002-07-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00032123) | SWOG Cancer Research Network | 2002-06-01 |
| Studying Genes for Barrett's Esophagus in Brothers and Sisters (NCT00516347) | Medical Research Council | 2002-06-01 |
| Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients (NCT00899626) | Vanderbilt University Medical Center | 2002-06-01 |
| Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer (NCT00047112) | Federation Francophone de Cancerologie Digestive | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00022139) | Alliance for Clinical Trials in Oncology | 2002-01-01 |
| Neoadjuvant Treatment Modalities in Esophageal Cancer (NCT04821843) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2002-01-01 |
| Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer (NCT00318903) | University of Alabama at Birmingham | 2002-01-01 |
| Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer (NCT00137852) | Dana-Farber Cancer Institute | 2002-01-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus (NCT00030862) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer (NCT00201747) | Ohio State University Comprehensive Cancer Center | 2001-09-01 |
| CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer (NCT00154804) | National Taiwan University Hospital | 2001-08-01 |
| Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer (NCT00165464) | Dana-Farber Cancer Institute | 2001-08-01 |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor (NCT00021047) | National Institutes of Health Clinical Center (CC) | 2001-07-01 |
| Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer (NCT00020787) | Jonsson Comprehensive Cancer Center | 2001-07-01 |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers (NCT00900419) | University of Colorado, Denver | 2001-05-03 |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery (NCT00011960) | Radiation Therapy Oncology Group | 2001-05-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer (NCT00025532) | University of California, San Francisco | 2001-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer (NCT00010270) | University Hospital Freiburg | 2001-04-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach (NCT00009880) | Radiation Therapy Oncology Group | 2001-04-01 |
| Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking (NCT00021138) | Personal Improvement Computer Systems | 2001-04-01 |
| DX-8951f in Treating Patients With Metastatic Stomach Cancer (NCT00017212) | Daiichi Sankyo | 2001-04-01 |
| S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus (NCT00012363) | SWOG Cancer Research Network | 2001-04-01 |
| S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach (NCT00004233) | SWOG Cancer Research Network | 2001-02-01 |
| BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy (NCT00017043) | Bristol-Myers Squibb | 2001-02-01 |
| BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy (NCT00017056) | Memorial Sloan Kettering Cancer Center | 2001-02-01 |
| Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer (NCT00154700) | National Taiwan University Hospital | 2001-01-01 |
| PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus (NCT00016900) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel (NCT00006245) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE) (NCT00165061) | Chinese University of Hong Kong | 2000-07-01 |
| Selective Dose Escalation for Esophageal Cancer (NCT00139633) | The Oregon Clinic | 2000-07-01 |
| Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus (NCT00005878) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-07-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma (NCT00215462) | Dana-Farber Cancer Institute | 2000-06-01 |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer (NCT00006081) | M.D. Anderson Cancer Center | 2000-06-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer (NCT00021320) | Fox Chase Cancer Center | 2000-05-01 |
| Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach (NCT00020761) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Genetic and Environmental Risk Factors Related to Esophageal Cancer (NCT01035398) | Massachusetts General Hospital | 2000-04-01 |
| Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer (NCT00004879) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery (NCT00005876) | Astex Pharmaceuticals, Inc. | 2000-04-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract (NCT00582647) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus (NCT00005607) | Robert H. Lurie Cancer Center | 2000-02-01 |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer (NCT00006038) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer (NCT00005599) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach (NCT00004127) | University of Chicago | 2000-02-01 |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach (NCT00004235) | Alliance for Clinical Trials in Oncology | 2000-01-01 |
| Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer (NCT00006472) | Medstar Health Research Institute | 2000-01-01 |
| Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer (NCT00004257) | Albany Medical College | 2000-01-01 |
| Positron Emission Tomography in Determining Stage of Esophageal Cancer (NCT00004867) | Alliance for Clinical Trials in Oncology | 1999-11-01 |
| Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer (NCT00004897) | Northwestern University | 1999-10-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer (NCT00005638) | Memorial Sloan Kettering Cancer Center | 1999-10-01 |